|
|
Volumn 4, Issue 4, 2007, Pages 385-387
|
|
The biospecimen as the key to personalizing medicine
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEFITINIB;
IMATINIB;
TRASTUZUMAB;
BREAST CANCER;
DISEASE PREDISPOSITION;
EDITORIAL;
GASTROINTESTINAL STROMAL TUMOR;
HIGH THROUGHPUT SCREENING;
HUMAN;
INFORMED CONSENT;
LABORATORY DIAGNOSIS;
LAW;
MEDICAL RECORD;
MEDICINE;
PATIENT CARE;
PATIENT PARTICIPATION;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PRIVACY;
PROGNOSIS;
RELIABILITY;
TREATMENT PLANNING;
TREATMENT RESPONSE;
TUMOR CLASSIFICATION;
|
|
EID: 37349044646
PISSN: 17410541
EISSN: 1744828X
Source Type: Journal
DOI: 10.2217/17410541.4.4.385 Document Type: Editorial |
|
Times cited : (1)
|
|
References (1)
|
